Ajanta Pharma Limited (AJANTPHARM) is an Indian multinational specialty pharmaceutical company founded in 1973 and headquartered in Mumbai, India. It develops, manufactures, and markets a wide range of quality pharmaceutical products, with a strong focus on branded generics in India and over 30 countries across Asia, Africa, and other emerging markets, as well as generic drugs in the United States market.<\/p>\n\n\n\n
The company’s product portfolio spans multiple therapeutic areas, including cardiology, dermatology, ophthalmology, and pain management, and is known for first-to-market and differentiated formulations. It operates seven state-of-the-art manufacturing facilities in India, some of which have US FDA and WHO approvals, and maintains a robust R&D infrastructure with hundreds of scientists working on innovative formulations.<\/p>\n\n\n\n
Ajanta Pharma’s mission is to serve global healthcare needs through empathy, innovation, and technology, aiming to deliver cost-effective and patient-centric medicines worldwide.<\/p>\n\n\n\n
Approved financial results of Q3 & 9 months FY 2026. The Board of Directors approved and took on record the unaudited financial results (consolidated and standalone) for the quarter and nine months ended 31 Dec 2025.<\/p>\n\n\n\n
Revenue from operations was \u20b91,375 crore, up 20%. EBITDA was \u20b9382 crore, up 19% with 28% margin. Profit After Tax (PAT) was \u20b9274 crore, up 18%<\/p>\n\n\n\n
Revenue from operations was \u20b94,031 crore, up 16%. EBITDA was \u20b91,061 crore, up 10% (margin 26%). PAT was \u20b9789 crore, up 14%. ROCE was 34% and RONW was 26%.<\/p>\n\n\n\n
Branded Generics (India, Asia & Africa) had growth in most markets, with strong performance in India and Africa. US Generics had significant growth with revenues up 52% for the quarter and 46% over 9M.<\/p>\n\n\n\n
Ajanta outpaced the Indian Pharmaceutical Market (IPM) with higher volume growth and new launches, especially in therapy areas like ophthalmology, dermatology, cardiology, and pain management.<\/p>\n\n\n\n
Multiple ANDAs filed, several approvals received, and products launched in the US market. Ongoing R&D investment noted as part of long-term growth strategy.<\/p>\n\n\n\n
Summary In short, Ajanta Pharma reported strong quarterly and nine-month growth in revenue and profit, with notable expansion in international markets and a robust pipeline of products under development\/approval.<\/p>\n","protected":false},"excerpt":{"rendered":"
About Ajanta Pharma Limited Ajanta Pharma Limited (AJANTPHARM) is an Indian multinational specialty pharmaceutical company founded in 1973 and headquartered in Mumbai, India. It develops, manufactures, and markets a wide range of quality pharmaceutical products, with a strong focus on branded generics in India and over 30 countries across Asia, Africa, and other emerging markets, […]<\/p>\n","protected":false},"author":2389,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5747,1941],"tags":[15211],"class_list":["post-178627","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-stocks","category-stock-analysis","tag-specialty-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169565,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q1-fy26-earnings-results-revenue-up-13-8-net-profit-up-3-7-yoy\/","url_meta":{"origin":178627,"position":0},"title":"Ajanta Pharma Ltd Q1 FY26 Earnings Results \u2013 Revenue Up 13.8%, Net Profit Up 3.7% YoY","author":"Divyansh_Kasana","date":"July 30, 2025","format":false,"excerpt":"Ajanta Pharma Limited is a specialty pharmaceutical company primarily engaged in the development, manufacturing, and marketing of high-quality finished dosage formulations. The company focuses on delivering innovative and affordable medicines across multiple therapeutic segments, strengthening its presence in domestic and international markets. Q1 FY26 Earnings Summary (Apr\u2013Jun 2025) Revenue: \u20b91,303\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/AJANTA.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172116,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-q2-fy26-earnings-results\/","url_meta":{"origin":178627,"position":1},"title":"Ajanta Pharma\u00a0Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 5, 2025","format":false,"excerpt":"Ajanta Pharma, specializing in specialty pharmaceutical manufacturing and marketing, reported a solid Q2 FY26 performance. Financial Overview: Revenues increased 14.07% to \u20b91,354 crore from \u20b91,187 crore. Total expenses rose 17.16% to \u20b91,072 crore from \u20b9915 crore. Net profit increased 20.37% to \u20b9260 crore from \u20b9216 crore. Earnings per share grew\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/AJNT.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":145168,"url":"https:\/\/alphastreet.com\/india\/earnings-ajanta-pharma-ltd-nse-ajantapharma-q4fy23-results-out-total-income-rises-2-1-yoy\/","url_meta":{"origin":178627,"position":2},"title":"Earnings | Ajanta Pharma Ltd. (NSE: AJANTAPHARMA): Q4FY23 Results Out; Total Income rises 2.1% YoY.","author":"Divyansh_Kasana","date":"May 5, 2023","format":false,"excerpt":"Ajanta Pharma is a leading Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of high-quality specialty pharmaceutical finished dosages. Founded in 1973, the company has a strong focus on research and development and has invested heavily in building state-of-the-art facilities and advanced technologies. Ajanta Pharma has a\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-21.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165443,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q2fy25-11-rise-in-profits\/","url_meta":{"origin":178627,"position":3},"title":"Ajanta Pharma Ltd Q2FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"November 7, 2024","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q2FY25 of \u20b91,187.00 Crores up from \u20b91,028.00 Crore year on year, a rise of 15.47%. Total Expenses for Q2FY25 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/LE.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168654,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q4fy25-11-rise-in-profits\/","url_meta":{"origin":178627,"position":4},"title":"Ajanta Pharma Ltd Q4FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"June 5, 2025","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q4FY25 of \u20b91,170.00 Crores up from \u20b91,054.00 Crore year on year, a rise of 11.01%. Total Expenses for Q4FY25 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167018,"url":"https:\/\/alphastreet.com\/india\/ajanta-pharma-ltd-q3fy25-11-rise-in-profits\/","url_meta":{"origin":178627,"position":5},"title":"Ajanta Pharma Ltd Q3FY25; 11% rise in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70). Financial Results: Ajanta Pharma Ltd reported Revenues for Q3FY25 of \u20b91,146.00 Crores up from \u20b91,105.00 Crore year on year, a rise of 3.71%. Total Expenses for Q3FY25 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/O-12.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2389"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=178627"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178627\/revisions"}],"predecessor-version":[{"id":178628,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178627\/revisions\/178628"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=178627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=178627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=178627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}